A rare case of multiple myeloma with several atypical manifestations

Published: 4 July 2024
Abstract Views: 77
PDF: 79
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

A 75-year-old woman presented asthenia and anemia after recurrent intestinal bleeding. Colonoscopy showed the presence of blood clots in the ascending colon, without active bleeding. During hospitalization, right toe cyanosis progressed to ischemic necrosis and was resistant to analgesics and vasodilators. The positron emission tomography-computed tomography scan showed a nodular thickening in the midfield of the right lung. Blood chemistry evidenced an Immunoglobulin (Ig) G-λ monoclonal peak. Multiple myeloma (MM) was diagnosed by bone marrow biopsy and serum/urine Ig-free chain dosage. The patient no longer had intestinal bleeding after the first MM chemotherapy (CHT). After 6 months of CHT, a partial hematological response and peripheral vascular improvement occurred. Extremely rare conditions may result in MM. In this case report, seemingly unrelated atypical manifestations co-existed and responded to hematological CHT for MM, confirming their association with the disease.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 2022;97:1086-107. DOI: https://doi.org/10.1002/ajh.26590
Padala SA, Barsouk A, Barsouk A, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci (Basel) 2021;9:3. DOI: https://doi.org/10.3390/medsci9010003
Cowan AJ, Allen C, Barac A, et al. Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016. JAMA Oncol 2018;4:1221-7. DOI: https://doi.org/10.1001/jamaoncol.2018.2128
Ayeboa-Sallah B, Qutab S, Grace R, Sharma N. Rare case of plasmablastic myeloma diagnosed on lung biopsy. BMJ Case Rep 2021;14:e240998. DOI: https://doi.org/10.1136/bcr-2020-240998
Albagoush SA, Shumway C, Azevedo AM. Multiple myeloma. 2023 Jan 30. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
Jagosky MH, Usmani SZ. Extramedullary disease in multiple myeloma. Curr Hematol Malig Rep 2020;15:62-71. DOI: https://doi.org/10.1007/s11899-020-00568-3
Waleed M, Ali AM, Saraj O, et al. A rare cause of lower GI bleeding. BMJ Case Rep 2012;2012:bcr0320126086. DOI: https://doi.org/10.1136/bcr.03.2012.6086
Chang SS, Lu CL, Tsay SH, et al. Amyloidosis-induced gastrointestinal bleeding in a patient with multiple myeloma. J Clin Gastroenterol 2001;32:161-3. DOI: https://doi.org/10.1097/00004836-200102000-00015
Chu CC, Chiu YH, Lin MH, et al. Immunoglobulin G kappa multiple myeloma with the only initial manifestation of Raynaud’s phenomenon. Scand J Rheumatol 2020;49:417-8. DOI: https://doi.org/10.1080/03009742.2020.1711965
Şahin Balçık Ö, Albayrak M, Dağdaş S, et al. A rare extramedullary involvement in myeloma: lung parenchyma and association with unfavorable chromosomal abnormalities. Turk J Haematol 2010;27:109-12. DOI: https://doi.org/10.5152/tjh.2010.08

How to Cite

Nasti, C., Natale, R., Morena, A., Della Pepa, R., Pasanisi, F., & Santarpia, L. (2024). A rare case of multiple myeloma with several atypical manifestations. Italian Journal of Medicine, 18(3). https://doi.org/10.4081/itjm.2024.1760